These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 25500100)

  • 1. Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trial.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Nichols FC; DiPetrillo TA; Meyers BF; Heron DE; Hillman SL; Jones DR; Starnes SL; Tan AD; Daly BD; Putnam JB;
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):718-25; discussion 725-6. PubMed ID: 25500100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron D; Jones DR; Daly BD; Starnes SL; Hatter JE; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):554-62. PubMed ID: 21724195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance).
    Kent MS; Mandrekar SJ; Landreneau R; Nichols F; DiPetrillo TA; Meyers B; Heron DE; Jones DR; Tan AD; Starnes S; Putnam JB; Fernando HC
    Ann Thorac Surg; 2016 Jul; 102(1):230-8. PubMed ID: 27101728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron DE; Jones DR; Daly BD; Starnes SL; Tan A; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1143-51. PubMed ID: 21872277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life evolution after lung cancer surgery: a prospective study in 100 patients.
    Balduyck B; Hendriks J; Lauwers P; Van Schil P
    Lung Cancer; 2007 Jun; 56(3):423-31. PubMed ID: 17306905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial.
    Su S; Scott WJ; Allen MS; Darling GE; Decker PA; McKenna RJ; Meyers BF
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):747-52: Discussion 752-3. PubMed ID: 24290575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients.
    Kent M; Landreneau R; Mandrekar S; Hillman S; Nichols F; Jones D; Starnes S; Tan A; Putnam J; Meyers B; Daly B; Fernando HC
    Ann Thorac Surg; 2013 Nov; 96(5):1747-54; discussion 1754-5. PubMed ID: 23998400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032).
    Kent MS; Mandrekar SJ; Landreneau R; Nichols F; Foster NR; DiPetrillo TA; Meyers B; Heron DE; Jones DR; Tan AD; Starnes S; Putnam JB; Fernando HC
    Ann Thorac Surg; 2016 Jul; 102(1):239-46. PubMed ID: 27101729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and survival after II stage nonsmall cell carcinoma surgery: Video-assisted thoracic surgery versus thoracotomy lobectomy.
    Zhao J; Zhao Y; Qiu T; Jiao W; Xuan Y; Wang X; Wang Y; Luo Y
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e130-3. PubMed ID: 26728671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).
    Crabtree T; Puri V; Timmerman R; Fernando H; Bradley J; Decker PA; Paulus R; Putnum JB; Dupuy DE; Meyers B
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):692-9. PubMed ID: 23174176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
    Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of life after lobectomy for early stage non-small cell lung cancer--video-assisted thoracoscopic surgery versus minimal incision thoracotomy].
    Long H; Lin ZC; Lin YB; Situ DR; Wang YN; Rong TH
    Ai Zheng; 2007 Jun; 26(6):624-8. PubMed ID: 17562269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Nichols FC; Hillman SL; Heron DE; Meyers BF; DiPetrillo TA; Jones DR; Starnes SL; Tan AD; Daly BD; Putnam JB
    J Clin Oncol; 2014 Aug; 32(23):2456-62. PubMed ID: 24982457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extent of lung parenchyma resection significantly impacts long-term quality of life in patients with non-small cell lung cancer.
    Schulte T; Schniewind B; Dohrmann P; Küchler T; Kurdow R
    Chest; 2009 Feb; 135(2):322-329. PubMed ID: 18689576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.
    Lee PC; Nasar A; Port JL; Paul S; Stiles B; Chiu YL; Andrews WG; Altorki NK
    Ann Thorac Surg; 2013 Sep; 96(3):951-60; discussion 960-1. PubMed ID: 23866808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative quality of life predicts survival following pulmonary resection in stage I non-small-cell lung cancer.
    Pompili C; Salati M; Refai M; Berardi R; Onofri A; Mazzanti P; Brunelli A
    Eur J Cardiothorac Surg; 2013 May; 43(5):905-10. PubMed ID: 23091229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial.
    Yang F; Sui X; Chen X; Zhang L; Wang X; Wang S; Wang J
    Trials; 2016 Apr; 17():191. PubMed ID: 27053091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life?
    Chambers A; Routledge T; Pilling J; Scarci M
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1015-21. PubMed ID: 20354037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.